BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Zonagen 

2408 Timberloch Place, Suite B-4

The Woodlands  Texas  77380-1012  U.S.A.
Phone: 281-367-5892 Fax: 281-363-8796


SEARCH JOBS

View Clinical Trials from BioPharm Insight



Industry
Biotechnology

Segment
Pharmaceuticals





 Company News
Zonagen (ZONA) Effects Name Change To Repros Therapeutics Inc. (RPRX) 5/3/2006 2:42:24 PM
Zonagen (ZONA) Reports First Quarter 2006 Financial Results 5/1/2006 1:03:23 PM
Zonagen (ZONA) Reports Fourth Quarter And Year End 2005 Financial Results 3/13/2006 1:24:26 PM
Zonagen (ZONA) Announces 2006 Annual Meeting Of Stockholders 2/8/2006 1:26:27 PM
Zonagen (ZONA) Announces Positive Top-Line Results Of Androxal(TM) Study 2/3/2006 11:13:36 AM
Zonagen (ZONA) Receives IRB Approval to Commence Phase III Study Of Androxal(TM) For The Treatment Of Testosterone Deficiency 1/9/2006 4:27:19 PM
Zonagen (ZONA) Announces U.S. IND For The Study Of Proellex(TM) In The Treatment Of Uterine Fibroids Has Become Effective 12/16/2005 1:12:00 PM
Zonagen (ZONA) Reports Third Quarter 2005 Financial Results And Provides Update On Proellex And Androxal Clinical Development Programs 11/11/2005 1:43:51 PM
Zonagen (ZONA) Reports Fourth Quarter And Year End 2004 Financial Results And Provides An Update On Company's Core Programs10/19/2005 5:13:10 PM
Zonagen (ZONA) Receives Notification Of Issuance Of U.S. Patent On Progenta10/19/2005 5:13:03 PM
12345